Cancer institute to tighten control of trials.
Gavaghan
H
H
D001943:Breast Neoplasms / Q000517:prevention & control / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D002986:Clinical Trials as Topic / Q000592:standards*; D005260:Female; D006801:Humans; D015412:Mastectomy, Segmental; D009316:National Institutes of Health (U.S.) / Q000592:standards*; D015871:Scientific Misconduct; D013629:Tamoxifen / Q000009:adverse effects / Q000627:therapeutic use; D014481:United States; D018172:United States Office of Research Integrity
D013629:Tamoxifen